Aligos Therapeutics, Inc. Common Stock (ALGS)

Typically moves ±5.50% on earnings
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-08-06 APPROXIMATE
search

Aligos Therapeutics, Inc. Common Stock (ALGS) has a 20-report earnings history dating back to Aug 05, 2021. Its average absolute post-earnings move is ±5.50%, and 45.0% of those reactions were positive. Its largest post-earnings gain was +20.16% (Aug 06, 2024) and its largest decline was -19.92% (Mar 10, 2025). The next earnings report is predicted for 2026-08-06 (approximate).

Earnings reactions

How ALGS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

20

Avg Abs. Movement

±5.50%

Positive %

45.0%

Negative %

55.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
May 07, 2026 ☽ POST +3.8% open_in_new
Mar 05, 2026 ☀ PRE -4.51% open_in_new
Nov 06, 2025 ☀ PRE -1.81% open_in_new
Aug 06, 2025 ☽ POST -0.37% open_in_new
event

Earnings Count

20

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.50%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 7 →
7
Funds holding
$1826795
Total value held
Buying
4 added · 2 reduced
Bank Of America Corp /De/
$1707072 +1652.78%
Blackrock, Inc.
$96887 Held
Royal Bank Of Canada
$16000 NEW BUY
Wells Fargo & Company/Mn
$5201 -53.33%
Morgan Stanley
$1619 -91.35%

Frequently asked about ALGS earnings

When does Aligos Therapeutics, Inc. Common Stock report earnings next? expand_more

Aligos Therapeutics, Inc. Common Stock (ALGS)'s next earnings date is approximate for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ALGS stock move after earnings? expand_more

Over 20 reports, ALGS has moved an average of ±5.50% the session after earnings, closing higher 45.0% of the time.

What was ALGS's biggest post-earnings move? expand_more

ALGS's largest post-earnings gain on record was +20.16% on Aug 06, 2024, and its largest decline was -19.92% on Mar 10, 2025.

Where can I find Aligos Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Aligos Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.